Quick Answer
BIOMERICA INC reported Diluted EPS of $2.16 per share (loss) for fiscal year 2025.
BIOMERICA INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$2.16 | +23.9% |
| 2024 | -$2.84 | -468.0% |
| 2023 | -$0.50 | -38.9% |
| 2022 | -$0.36 | +41.9% |
| 2021 | -$0.62 | -169.6% |
| 2020 | -$0.23 | +11.5% |
| 2019 | -$0.26 | -52.9% |
| 2018 | -$0.17 | -54.5% |
| 2017 | -$0.11 | +45.0% |
| 2016 | -$0.20 | -400.0% |
| 2015 | -$0.04 | -33.3% |
| 2014 | -$0.03 | -142.9% |
| 2013 | $0.07 | -12.5% |
| 2012 | $0.08 | +300.0% |
| 2011 | $0.02 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | -$0.45 | -650.0% | — |
| August 31, 2025 | $0.00 | +100.0% | +100.0% |
| February 28, 2025 | -$0.06 | +45.5% | +0.0% |
| November 30, 2024 | -$0.06 | +33.3% | +90.5% |
| August 31, 2024 | -$0.63 | -800.0% | -472.7% |
| February 29, 2024 | -$0.11 | +8.3% | -22.2% |
| November 30, 2023 | -$0.09 | +25.0% | -28.6% |
| August 31, 2023 | -$0.07 | +56.2% | +41.7% |
- BIOMERICA INC showed an increase of +23.9% in Diluted EPS compared to the prior fiscal year.
- Over the 2011–2025 period, BIOMERICA INC’s diluted eps has declined by 10900.0% (from $0.02 per share to $2.16 per share (loss)).
- The most recent figure is from BIOMERICA INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on August 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: